Real-world effectiveness of antipsychotic treatment in psychosis prevention in a 3-year cohort of 517 individuals at clinical high risk from the SHARP (ShangHai At Risk for Psychosis)

Objective: Antipsychotics are widely used for treating psychosis, but it is unclear whether they can also prevent psychosis. This study attempted a longitudinal evaluation of antipsychotics under real-world conditions in China to evaluate their effect on the rate of conversion to psychosis in individuals with a clinical high risk (CHR) of psychosis. Method: A total of 517 CHR individuals were recruited between 2011 and 2016 and followed up for 3 years. Among these, 450 (87.0%) individuals completed follow-up, 108 (24.0%) showed conversion to psychosis and 309 (68.7%) received antipsychotics. The main outcome was conversion to psychosis. The sample was further stratified according to the severity of positive symptoms. Results: Patients who did not receive antipsychotics showed a lower conversion rate than those who did (17.7% vs 26.9%; odds ratio [OR] = 0.660, 95% confidence interval [CI] = [0.442, 0.985], p = 0.035). In mild CHR cases, antipsychotic treatment was more likely to be associated with conversion to psychosis, compared with the no-antipsychotics group, with no such difference observed in severe CHR cases. Among those who received antipsychotics, monotherapy or low-dose treatment was associated with lower conversion rates. Our results did not favor any specific type of antipsychotics and suggested that a very small subgroup of CHR individuals with severe positive and general symptoms but mild negative symptoms may benefit from antipsychotic treatment. Conclusions: Administration of antipsychotics to CHR patients is potentially harmful with no preventive benefits. We do not recommend antipsychotic treatment for CHR individuals, which is practiced widely in China, and strongly advise caution if these drugs are used.

[1]  Chunbo Li,et al.  Isolated hallucination is less predictive than thought disorder in psychosis: Insight from a longitudinal study in a clinical population at high risk for psychosis , 2018, Scientific Reports.

[2]  R. McCarley,et al.  Prediction of psychosis in prodrome: development and validation of a simple, personalized risk calculator , 2018, Psychological Medicine.

[3]  R. McCarley,et al.  S105. VALIDATING THE PREDICTIVE ACCURACY OF THE NAPLS-2 PSYCHOSIS RISK CALCULATOR IN A CLINICAL HIGH-RISK SAMPLE FROM THE SHARP (SHANGHAI AT RISK FOR PSYCHOSIS) PROGRAM , 2018, The American journal of psychiatry.

[4]  L. Seidman,et al.  A comparison of conversion rates, clinical profiles and predictors of outcomes in two independent samples of individuals at clinical high risk for psychosis in China , 2017, Schizophrenia Research.

[5]  C. Correll,et al.  A Severity-Based Clinical Staging Model for the Psychosis Prodrome: Longitudinal Findings From the New York Recognition and Prevention Program , 2017, Schizophrenia bulletin.

[6]  John M. Davis,et al.  Dose Equivalents for Antipsychotic Drugs: The DDD Method. , 2016, Schizophrenia bulletin.

[7]  A. Jablensky,et al.  Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders , 2016, The Australian and New Zealand journal of psychiatry.

[8]  L. Seidman,et al.  Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion , 2016, Epidemiology and Psychiatric Sciences.

[9]  T. Furukawa,et al.  Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. , 2015, Journal of affective disorders.

[10]  L. Seidman,et al.  Interaction of social role functioning and coping in people with recent-onset attenuated psychotic symptoms: a case study of three Chinese women at clinical high risk for psychosis , 2015, Neuropsychiatric disease and treatment.

[11]  J. Boyd,et al.  Stigma of taking psychiatric medications among psychiatric outpatient veterans. , 2015, Psychiatric rehabilitation journal.

[12]  M. Nordentoft,et al.  EPA guidance on the early intervention in clinical high risk states of psychoses , 2015, European Psychiatry.

[13]  L. Seidman,et al.  Prodromal psychosis detection in a counseling center population in China: An epidemiological and clinical study , 2014, Schizophrenia Research.

[14]  T. McGlashan,et al.  The psychosis high-risk state: a comprehensive state-of-the-art review. , 2013, JAMA psychiatry.

[15]  P. McGuire,et al.  Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. , 2012, Archives of general psychiatry.

[16]  A. Yung,et al.  Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis. , 2011, The Journal of clinical psychiatry.

[17]  T. McGlashan,et al.  The Psychosis-Risk Syndrome: Handbook for Diagnosis and Follow-Up , 2010 .

[18]  S. Leucht,et al.  How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials , 2009, Molecular Psychiatry.

[19]  Tyrone D. Cannon,et al.  Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. , 2008, Archives of general psychiatry.

[20]  P. McGuire,et al.  Can antidepressants prevent psychosis? , 2007, The Lancet.

[21]  Adrian Preda,et al.  Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. , 2006, The American journal of psychiatry.

[22]  R. Bentall,et al.  Cognitive therapy for the prevention of psychosis in people at ultra-high risk , 2004, British Journal of Psychiatry.

[23]  Godfrey D Pearlson,et al.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. , 2003, Schizophrenia bulletin.

[24]  Hok Pan Yuen,et al.  Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. , 2002, Archives of general psychiatry.

[25]  T. McGlashan,et al.  Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. , 2002, The American journal of psychiatry.